Home / Resource Library / Induction of neutralizing antibodies in CLL patients after SARS‑CoV‑2 mRNA vaccination: a monocentric experienceInduction of neutralizing antibodies in CLL patients after SARS‑CoV‑2 mRNA vaccination: a monocentric experience